Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex

Captopril is the first angiotensin I-converting enzyme inhibitor widely used for the treatment of hypertension. Based on the well-known benefits of cyclodextrin inclusion complexes, the present study investigated the ability of β-cyclodextrin to include captopril. Solid inclusion complexes of captop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Musuc, Adina Magdalena, Anuta, Valentina, Atkinson, Irina, Popa, Vlad Tudor, Sarbu, Iulian, Mircioiu, Constantin, Abdalrb, Ghaleb Abdalameer, Mitu, Mirela Adriana, Ozon, Emma Adriana
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464127/
https://ncbi.nlm.nih.gov/pubmed/32784691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12080744
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados